Traders sold shares of Henry Schein, Inc. (NASDAQ:HSIC) on strength during trading on Tuesday. $20.11 million flowed into the stock on the tick-up and $47.45 million flowed out of the stock on the tick-down, for a money net flow of $27.34 million out of the stock. Of all stocks tracked, Henry Schein had the 28th highest net out-flow for the day. Henry Schein traded up $0.54 for the day and closed at $82.45

A number of brokerages have recently issued reports on HSIC. Stifel Nicolaus reaffirmed a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. BidaskClub lowered Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Finally, UBS AG reaffirmed a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have given a buy rating to the company’s stock. Henry Schein has a consensus rating of “Hold” and an average target price of $92.14.

The firm has a 50-day moving average price of $82.72 and a 200-day moving average price of $87.37. The company has a market cap of $13.04 billion, a P/E ratio of 24.09 and a beta of 1.09.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. During the same quarter last year, the firm earned $0.82 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post $3.64 EPS for the current fiscal year.

Henry Schein announced that its board has initiated a stock repurchase program on Monday, September 18th that allows the company to buyback $400.00 million in outstanding shares. This buyback authorization allows the company to buy up to 6.3% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

In other news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.19% of the stock is owned by company insiders.

Hedge funds have recently bought and sold shares of the company. YorkBridge Wealth Partners LLC boosted its holdings in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares during the last quarter. Sun Life Financial INC boosted its holdings in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after acquiring an additional 573 shares during the last quarter. Lee Financial Co acquired a new position in Henry Schein in the second quarter valued at $161,000. Acrospire Investment Management LLC boosted its holdings in Henry Schein by 150.0% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after acquiring an additional 600 shares during the last quarter. Finally, HM Payson & Co. acquired a new position in Henry Schein in the second quarter valued at $204,000. Institutional investors and hedge funds own 44.74% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/investors-sell-henry-schein-inc-hsic-on-strength-hsic/1637311.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.